GB1147731A - Improvements relating to the stabilization of chlormethiazole - Google Patents
Improvements relating to the stabilization of chlormethiazoleInfo
- Publication number
- GB1147731A GB1147731A GB976267A GB976267A GB1147731A GB 1147731 A GB1147731 A GB 1147731A GB 976267 A GB976267 A GB 976267A GB 976267 A GB976267 A GB 976267A GB 1147731 A GB1147731 A GB 1147731A
- Authority
- GB
- United Kingdom
- Prior art keywords
- chlormethiazole
- march
- stabilization
- stabilized
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- PCLITLDOTJTVDJ-UHFFFAOYSA-N Chlormethiazole Chemical compound CC=1N=CSC=1CCCl PCLITLDOTJTVDJ-UHFFFAOYSA-N 0.000 title abstract 6
- 229960004414 clomethiazole Drugs 0.000 title abstract 6
- 230000006641 stabilisation Effects 0.000 title 1
- 238000011105 stabilization Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 abstract 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005642 Oleic acid Substances 0.000 abstract 1
- 235000019483 Peanut oil Nutrition 0.000 abstract 1
- 235000021355 Stearic acid Nutrition 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000011872 intimate mixture Substances 0.000 abstract 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
- 239000000312 peanut oil Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000011343 solid material Substances 0.000 abstract 1
- 239000008117 stearic acid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE303166A SE319577B (enrdf_load_stackoverflow) | 1966-03-08 | 1966-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1147731A true GB1147731A (en) | 1969-04-02 |
Family
ID=20261249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB976267A Expired GB1147731A (en) | 1966-03-08 | 1967-03-01 | Improvements relating to the stabilization of chlormethiazole |
Country Status (6)
| Country | Link |
|---|---|
| AT (1) | AT266126B (enrdf_load_stackoverflow) |
| BE (1) | BE693977A (enrdf_load_stackoverflow) |
| DE (1) | DE1617286B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1147731A (enrdf_load_stackoverflow) |
| NL (1) | NL156921B (enrdf_load_stackoverflow) |
| SE (1) | SE319577B (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT358530B (de) * | 1978-04-25 | 1980-09-10 | Plc Pharma Licences | Stabilisierungsverfahren |
-
1966
- 1966-03-08 SE SE303166A patent/SE319577B/xx unknown
-
1967
- 1967-02-09 NL NL6702002A patent/NL156921B/xx not_active IP Right Cessation
- 1967-02-09 DE DE1967A0054844 patent/DE1617286B1/de active Pending
- 1967-02-13 BE BE693977D patent/BE693977A/xx not_active IP Right Cessation
- 1967-02-16 AT AT151867A patent/AT266126B/de active
- 1967-03-01 GB GB976267A patent/GB1147731A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6702002A (enrdf_load_stackoverflow) | 1967-09-11 |
| AT266126B (de) | 1968-11-11 |
| NL156921B (nl) | 1978-06-15 |
| DE1617286B1 (de) | 1971-05-27 |
| SE319577B (enrdf_load_stackoverflow) | 1970-01-19 |
| BE693977A (enrdf_load_stackoverflow) | 1967-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8500739A1 (es) | Metodo de producir composiciones farmaceuticas de liberacion controlada y accion prolongada | |
| PT71724A (en) | Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vassodi lator effect and of pharmaceutical compositions containing thern | |
| DE3665668D1 (en) | Pharmaceutical granulate containing ambroxol or bromohexine | |
| GB1147731A (en) | Improvements relating to the stabilization of chlormethiazole | |
| JPS52108028A (en) | Remedies for dysacousis | |
| IL45136A0 (en) | Process for the preparation of 3-(0,0-diethyldithiophosphorylmethyl)-6-chloro-benzoxazolone and insecticidal and acaricidal compositions containing same | |
| JPS57109721A (en) | Carcinostatic agent | |
| JPS5347515A (en) | Gamma-globulin pharmaceutical preparation for intravenous injection | |
| JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
| ES337954A1 (es) | Un metodo de preparar nuevas benzotriazinonas. | |
| JPS5269950A (en) | Polyolefin compositions with improved now-fogging and antistatic prope rties | |
| JPS5640607A (en) | Drug composition | |
| JPS54151925A (en) | Nn*1**methoxycarbonylethyl**nn*n**n** disubstituted hydrazinoacetyl**aniline derivative*its manufacture and fungicidal composition containing it as active component | |
| IL46194A (en) | 10,11-dihydro-dibenz(b,f)/xepine derivatives,their preparation and pharmaceutical compositions containing certain of these compounds | |
| JPS5668611A (en) | Novel antiallergic agent | |
| JPS5283429A (en) | Preparation of aromatic unsaturated carboxylic acid amide derivatives | |
| JPS5584334A (en) | Anti-static resin composition | |
| JPS51136886A (en) | New biologica lly active substance, ml-236c, and its preparation | |
| GB1294538A (en) | Pharmaceutical compositions | |
| SE7409378L (enrdf_load_stackoverflow) | ||
| JPS57159711A (en) | Low oxygen cell sensitizer for radiation | |
| ES347270A1 (es) | Procedimiento para preparar benzodiazapinas. | |
| JPS5251362A (en) | Preparation of optically active pyrrolidine derivatives | |
| JPS5742620A (en) | Novel antiulcer agent | |
| GB1138154A (en) | Improvements in and relating to safeguarding composition containing physiologically active ingredient |